ER Positive, HER2 Negative Breast Cancer
Also known as: ER-Positive, HER2-Negative Breast Cancer / ER-Positive HER2-Negative Breast Cancer
| Drug | Drug Name | Drug Description |
|---|
| Drug | Drug Name | Target | Type |
|---|
| Drug | Drug Name | Phase | Status | Count |
|---|---|---|---|---|
| DB17456 | Dalpiciclib | 1 | Recruiting | 1 |
| DB01006 | Letrozole | 2 | Unknown Status | 1 |
| DB09073 | Palbociclib | 2 | Unknown Status | 1 |
| DB12001 | Abemaciclib | 3 | Recruiting | 1 |
| DB01217 | Anastrozole | 3 | Active Not Recruiting | 1 |
| DB01217 | Anastrozole | 3 | Recruiting | 1 |
| DB01006 | Letrozole | 3 | Recruiting | 1 |
| DB14741 | Luteinizing hormone | 3 | Active Not Recruiting | 1 |
| DB14741 | Luteinizing hormone | 3 | Recruiting | 1 |
| DB09073 | Palbociclib | 3 | Active Not Recruiting | 1 |
| DB09073 | Palbociclib | 3 | Recruiting | 1 |
| DB11730 | Ribociclib | 3 | Recruiting | 1 |